BioSpace News Archive

Aurinia Pharmaceuticals Inc. announced that it will release financial and operational results for the third quarter of 2023, on Thursday, November 2, 2023, before markets open.

Emergent BioSolutions Inc. will host a conference call on Thursday, November 2, 2023, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2023, recent business developments, and financial outlook for full year 2023.

Karuna Therapeutics, Inc. (NASDAQ: KRTX) today announced that it will host a live conference call and webcast on Thursday, November 2, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and provide a general business update.

Bio-Techne Corporation announced that its Board of Directors appointed Kim Kelderman as President and Chief Executive Officer effective February 1, 2024.

Tonix Pharmaceuticals Holding Corp. presented data on its horsepox-based live virus vaccine platform in an oral presentation at the World Vaccine Congress Europe being held in Barcelona, Spain, October 16-19, 2023.

Element Biosciences, Inc. will present new data from customers in oncology and immunology and highlight AVITI’s higher accuracy sequencing for research in rare and undiagnosed genetic disease and other research applications at the American Society of Human Genetics (ASHG) annual meeting on Nov. 1-5, 2023, in Washington D.C.

Acurx Pharmaceuticals, Inc. today announced three scientific posters were presented during the 13th International Conference on Molecular Biology and Pathogenesis of Clostridia (ClostPath) held in Banff, Canada from September 19 to 23, 2023.

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the third quarter and nine months ended Sept. 30, 2023, after the close of market on Thursday, Nov. 2, 2023.

Anumana, Inc today announced that Maulik Nanavaty has joined Anumana as chief executive officer and member of the Board of Directors.

Foundation Medicine, Inc., today announced that the company will present 11 abstracts demonstrating the value of high-quality biomarker tests to inform cancer care at the 2023 European Society for Medical Oncology (ESMO) Annual Meeting from October 20-24 in Madrid, Spain.